SPDR S&P Pharmaceuticals ETF
XPH
XPH
71 hedge funds and large institutions have $105M invested in SPDR S&P Pharmaceuticals ETF in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 10 closing their positions.
Holders
71
Holders Change
+2
Holders Change %
+2.9%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
22
Reduced
18
Closed
10
Calls
$3K
Puts
$853K
Net Calls
-$850K
Net Calls Change
-$514K
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MCC
76
Money Concepts Capital
Palm Beach Gardens,
Florida
| – | – | -1,312 | Closed |
|
|
CWM
77
Cedar Wealth Management
Walnut Creek,
California
| – | – | -300 | Closed |
|
78
Creative Planning
Overland Park,
Kansas
| – | – | -201 | Closed |
|
|
PA
79
PSI Advisors
Tampa,
Florida
| – | – | -150 | Closed |
|
|
CA
80
Clearstead Advisors
Cleveland,
Ohio
| – | – | -26 | Closed |
|
81
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | – | -12 | Closed |
|
82
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|
|
HNB
83
Huntington National Bank
Columbus,
Ohio
| – | – | – | – |
|